CATALOGO DEI PRODOTTI DELLA RICERCA

LAWLOR, Rita Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.676
EU - Europa 5.536
AS - Asia 4.985
SA - Sud America 873
AF - Africa 158
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.540
SG - Singapore 1.873
CN - Cina 1.635
GB - Regno Unito 1.295
IT - Italia 1.253
BR - Brasile 783
HK - Hong Kong 721
DE - Germania 534
RU - Federazione Russa 521
IE - Irlanda 459
SE - Svezia 398
FR - Francia 375
FI - Finlandia 219
VN - Vietnam 184
KR - Corea 169
NL - Olanda 122
AT - Austria 74
CA - Canada 72
IN - India 69
UA - Ucraina 67
TG - Togo 50
JP - Giappone 45
ES - Italia 42
BE - Belgio 40
JO - Giordania 39
MX - Messico 39
ID - Indonesia 37
AU - Australia 36
TR - Turchia 35
BD - Bangladesh 29
PL - Polonia 29
ZA - Sudafrica 25
IR - Iran 23
AR - Argentina 21
MA - Marocco 19
PK - Pakistan 17
CZ - Repubblica Ceca 15
BF - Burkina Faso 14
CO - Colombia 14
IQ - Iraq 14
VE - Venezuela 14
CL - Cile 13
EC - Ecuador 13
LT - Lituania 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
KE - Kenya 12
BG - Bulgaria 9
KG - Kirghizistan 9
NG - Nigeria 9
CH - Svizzera 8
MY - Malesia 7
AZ - Azerbaigian 6
EG - Egitto 6
IL - Israele 6
LV - Lettonia 6
NP - Nepal 6
PA - Panama 6
PH - Filippine 6
PT - Portogallo 6
PY - Paraguay 6
TN - Tunisia 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
ET - Etiopia 4
LU - Lussemburgo 4
MD - Moldavia 4
RO - Romania 4
RS - Serbia 4
AD - Andorra 3
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HU - Ungheria 3
IS - Islanda 3
MK - Macedonia 3
NO - Norvegia 3
PE - Perù 3
PS - Palestinian Territory 3
UG - Uganda 3
UY - Uruguay 3
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
BZ - Belize 2
CI - Costa d'Avorio 2
CY - Cipro 2
DZ - Algeria 2
EU - Europa 2
GA - Gabon 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
OM - Oman 2
Totale 17.255
Salva come PNG Salva come JPEG
Città #
Southend 1.154
Chandler 945
Singapore 890
Dallas 839
Hong Kong 710
Verona 589
Dublin 425
Beijing 348
Ashburn 320
Jacksonville 246
Ann Arbor 213
New York 208
Woodbridge 182
Munich 169
Lawrence 134
Princeton 134
Wilmington 130
Jinan 123
The Dalles 117
Houston 98
Nanjing 93
Shenyang 88
Redmond 87
Dong Ket 82
Columbus 81
Helsinki 76
Sindelfingen 66
Hebei 65
Santa Clara 61
Nuremberg 59
São Paulo 59
Los Angeles 57
Zhengzhou 57
Lomé 50
Seattle 50
Turku 49
Vienna 42
Brussels 40
Haikou 40
Amman 39
Changsha 39
Ningbo 38
Milan 37
Hangzhou 36
Tianjin 36
Guangzhou 34
Taizhou 34
Jakarta 33
Nanchang 33
Jiaxing 32
Washington 32
Lappeenranta 31
Redwood City 30
Taiyuan 30
Brescia 29
Council Bluffs 29
Frankfurt am Main 28
Tokyo 28
Dearborn 27
Seoul 27
Bologna 26
Madrid 26
Ho Chi Minh City 25
Brooklyn 23
Chicago 23
Moscow 23
Belo Horizonte 22
London 22
San Francisco 22
Amsterdam 21
Curitiba 21
Kent 21
Rio de Janeiro 21
Toronto 21
Shanghai 20
Boardman 19
Stockholm 18
Warsaw 18
Hanoi 17
Chions 16
Lancaster 16
Fairfield 15
Norwalk 15
Bobo-Dioulasso 14
Brasília 14
Sydney 14
Fuzhou 13
Mexico City 13
Phoenix 13
Rome 13
Brno 12
Buffalo 12
Falls Church 12
Johannesburg 12
Montreal 12
Tashkent 12
Campinas 11
Manchester 11
Salvador 11
Dongguan 10
Totale 10.538
Salva come PNG Salva come JPEG
Nome #
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 433
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 204
Whole-genome landscape of pancreatic neuroendocrine tumours 203
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 195
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 192
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 179
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 176
Genomic characterization of hepatoid tumors: context matters 168
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 167
Genomic analyses identify molecular subtypes of pancreatic cancer 166
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 156
RON is not a prognostic marker for resectable pancreatic cancer 153
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 153
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 150
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 149
Reporting tumor molecular heterogeneity in histopathological diagnosis 145
Gα15 in early onset of pancreatic ductal adenocarcinoma 144
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 141
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 138
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 137
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 135
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 132
Splice variants as novel targets in pancreatic ductal adenocarcinoma 131
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 131
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 129
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 128
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 127
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 126
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 126
Lost in translation: returning germline genetic results in genome-scale cancer research 124
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 123
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 122
International network of cancer genome projects 121
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 121
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 121
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 121
Research capacity. Enabling the genomic revolution in Africa 119
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 117
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 116
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 115
Hypermutation In Pancreatic Cancer 114
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 114
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 113
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 112
Biosampling and biobanking (Chapter7) 112
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 111
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 111
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 110
Sex differences in oncogenic mutational processes 110
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 110
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 109
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 109
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 108
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 108
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 108
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 107
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 107
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 106
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 106
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 106
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 106
Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by (1)H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution 105
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 104
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 104
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 102
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 101
Whole genomes redefine the mutational landscape of pancreatic cancer 101
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 101
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 101
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 99
Exosomal miRNA signatures of pancreatic lesions 99
Comparative Lesions Analysis Through a Targeted Sequencing Approach 98
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 98
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 97
Genome-wide association study identifies an early onset pancreatic cancer risk locus 97
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 96
The Global Genome Biodiversity Network (GGBN) Data Standard specification 95
A multimodality test to guide the management of patients with a pancreatic cyst 95
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 94
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 94
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 94
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 94
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 93
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 93
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 93
Divergent mutational processes distinguish hypoxic and normoxic tumours 92
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 92
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 92
Building capacity for sustainable research programmes for cancer in Africa 91
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 91
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 91
Germline BRCA2 K3326X and CHEK2 I157T Mutations Increase Risk for Sporadic Pancreatic Ductal Adenocarcinoma 91
Reduced risk of pancreatic cancer associated with asthma and nasal allergies 90
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 90
Combined microRNA and mRNA microfluidic TaqMan array cards for the diagnosis of malignancy of multiple types of pancreatico-biliary tumors in fine-needle aspiration material 89
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 89
Pan-cancer analysis of whole genomes 88
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 86
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 86
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 86
Totale 12.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.874
article - articoli 67.937
book - libri 933
conference - conferenze 1.018
curatela - curatele 0
other - altro 875
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.111
Totale 143.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021893 0 0 75 179 140 110 35 24 43 45 90 152
2021/20221.318 127 354 75 114 52 33 54 90 51 32 81 255
2022/20232.624 160 320 203 439 219 619 45 165 291 35 89 39
2023/20241.877 57 124 125 168 177 330 95 192 56 129 305 119
2024/20255.563 298 285 329 815 309 299 429 340 704 346 522 887
2025/20262.441 1.058 735 648 0 0 0 0 0 0 0 0 0
Totale 17.758